No awards were granted during the six-month period ended June 30, 2020. As of June 30, 2020, there was $102,000 of total unrecognized compensation cost related to non-vested options granted in 2019 under the 2014 Equity Incentive Plan, which will be fully amortized by December 31, 2020. Compensation costs related to stock options amounted to $102,000 and $104,000 during the six-month periods ended June 30, 2020 and 2019, respectively.

A summary of the Company’s stock option activity for the six-month period ended June 30, 2020 is as follows:



		Weighted
		Average Exercise		Weighted Average		Aggregate
		Price		Remaining		Intrinsic Value
	Options	Per Share		Contractual Term		($000)
Outstanding at January 1, 2020	199,825	$	24.78	5.9	Yrs.	$	2,822
Granted	—		—	—			—
Exercised	(2,005)		19.25	5.8	Yrs.		—
Forfeited	—		—				—
Outstanding at June 30, 2020	197,820	$	24.83	5.4	Yrs.	$	728
Exercisable at June 30, 2020	171,070	$	23.08	4.8	Yrs.	$	728

Intrinsic value represents the amount by which the market price of the stock on the measurement date exceeded the exercise price of the option. The market price was $24.79 per share as of June 30, 2020 and $38.90 per share as of December 31, 2019.

A summary of the Company’s restricted stock activity for the six-month periods ended June 30, 2020 and 2019 is as follows:



	2020			2019
		Weighted-Average				Weighted-Average
	Number of	Grant Date		Number of	Grant Date
	Restricted Stock	Fair Value		Restricted Stock	Fair Value
Non-vested, January 1,	36,195	$	36.23	34,615	$	27.82
Granted	—		—	—		—
Vested	—		—	—		—
Forfeited	—		—	—		—
Non-vested, June 30,	36,195	$	36.23	34,615	$	27.82

The expected future compensation expense relating to the 36,195 shares of non-vested restricted stock outstanding as of June 30, 2020 is $979,000. This cost will be recognized over the remaining vesting period of 4.5 years. Compensation costs related to restricted stock amounted to $167,000 and $145,000 during the six-month periods ended June 30, 2020 and 2019, respectively.